These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10442552)

  • 21. Hormonal regulation of an estramustine-binding protein in the submaxillary gland of the rat.
    Pousette A; Björk P; Carlström K
    J Steroid Biochem; 1987 Jan; 26(1):31-4. PubMed ID: 3493389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of estramustine binding protein: its relationship to androgen dependency and histological differentiation in human prostatic carcinoma tissue.
    Shiina H; Sumi H; Ishibe T; Usui T
    Urol Int; 1994; 52(4):213-6. PubMed ID: 8030169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
    Björk P; Jönsson U; Andrén-Sandberg A
    Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific binding of estramustine to prostatic proteins.
    Forsgren B; Björk P
    Urology; 1984 Jun; 23(6 Suppl):34-8. PubMed ID: 6375077
    [No Abstract]   [Full Text] [Related]  

  • 25. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol.
    Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The presence in rat and human prostate of proteins that bind steroid-cytostatic complexes.
    Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
    Prog Clin Biol Res; 1981; 75A():391-407. PubMed ID: 7339627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the estramustine-binding protein in rat ventral prostate and in human prostate.
    Gustafsson JA; Björk P; Carlström K; Forsgren B; Hökfelt T; Pousette A; Högberg B
    Scand J Urol Nephrol Suppl; 1980; 55():133-4. PubMed ID: 6163205
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of estramustine-binding protein in ependymomas and in human and developing rat ependymal cells.
    Bergenheim AT; Hartman M; Bergh J; Ridderheim PA; Henriksson R
    J Neurooncol; 1994; 22(1):45-53. PubMed ID: 7714550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of estramustine-binding protein during postnatal development of rat brain.
    Karlsson AE; Bergenheim AT; Brännström T; Hedman H; Henriksson R
    Histochem Cell Biol; 2001 May; 115(5):397-401. PubMed ID: 11449887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of estramustine phosphate.
    Bergenheim AT; Henriksson R
    Clin Pharmacokinet; 1998 Feb; 34(2):163-72. PubMed ID: 9515186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrophilin immunoreactivity versus estrogen receptor binding activity in meningiomas: evidence for multiple estrogen binding sites.
    Lesch KP; Schott W; Gross S
    Surg Neurol; 1987 Sep; 28(3):181-8. PubMed ID: 3306997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of estramustine and pregnenolone binding to prostatic binding protein: evidence for subunit cooperativity.
    Heyns W; Bossyns D
    J Steroid Biochem; 1983 Dec; 19(6):1689-94. PubMed ID: 6686985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinogen-binding proteins in the rat ventral prostate: specific and nonspecific high-affinity binding sites for benzo(a)pyrene, 3-methylcholanthrene, and 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Söderkvist P; Poellinger L; Gustafsson JA
    Cancer Res; 1986 Feb; 46(2):651-7. PubMed ID: 3940634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression.
    Shiina H; Igawa M; Ishibe T
    Br J Urol; 1996 Jan; 77(1):96-101. PubMed ID: 8653325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic cleavage of high-molecular-weight microtubule-associated proteins by the prostatic estramustine-binding protein.
    Rutberg M; Fridén B; Björk P; Wallin M
    Prostate; 1989; 15(4):287-97. PubMed ID: 2687823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine.
    Speicher LA; Barone LR; Chapman AE; Hudes GR; Laing N; Smith CD; Tew KD
    J Natl Cancer Inst; 1994 May; 86(9):688-94. PubMed ID: 7908988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical study on estramustine binding protein (EMBP) in human prostate.
    Shiina H; Igawa M; Ishibe T
    Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta.
    Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3149-53. PubMed ID: 290993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estramustine binding protein in primary tumours and metastases of malignant melanoma.
    von Schoultz E; Carlström K; Henriksson R; Lagerlöf B; Hansson J
    Melanoma Res; 1994 Dec; 4(6):401-5. PubMed ID: 7703721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines.
    von Schoultz E; Lundblad D; Bergh J; Grankvist K; Henriksson R
    Br J Cancer; 1988 Sep; 58(3):326-9. PubMed ID: 3052561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.